US wants Australia to modify its cheap drugs scheme as part of trade deal
BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7391.680/c (Published 29 March 2003) Cite this as: BMJ 2003;326:680- Bob Burton
- Canberra
US government negotiators are pressing the Australian government to agree to modifications to the government subsidised pharmaceutical benefits scheme in exchange for allowing Australian farmers better access to US markets, as part of a free trade agreement.
Under the scheme, the Australian government subsidises approved drugs and negotiates heavily discounted prices from the manufacturer. Patients, who pay what is often a nominal “co-payment” on a prescription, are then able to receive them far more cheaply than they otherwise would.
Assistant US trade representative Ralph Ives confirmed at the conclusion of the first week's negotiations in Canberra that the scheme was on the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.